Cost Analysis of Monitoring Asthma Treatment using Sputum Cell Counts
BACKGROUND: In a four-centre trial, the use of sputum cell counts (sputum strategy [SS]) to guide treatment had resulted in fewer and less severe exacerbations without the need for a higher corticosteroid dose, compared with the use of symptoms and spirometry (clinical strategy [CS]).
Saved in:
Main Authors: | Liesel D’silva, Amiram Gafni, Lehana Thabane, Lata Jayaram, Pat Hussack, Frederick E Hargreave, Parameswaran Nair |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2008/946735 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Evolution of Sputum Cytometry to Assess Bronchitis
by: Hui Fang Lim, et al.
Published: (2013-01-01) -
Nonasthmatic Chronic Cough: No Effect of Treatment with an Inhaled Corticosteriod in Patients without Sputum Eosinophilia
by: Marcia MM Pizzichini, et al.
Published: (1999-01-01) -
Induced sputum is a reproducible method to assess airway inflammation in asthma
by: Elena Bacci, et al.
Published: (2002-01-01) -
Predictors of Loss of Asthma Control Induced by Corticosteroid Withdrawal
by: Jose Belda, et al.
Published: (2006-01-01) -
Total immunoglobulin E levels in induced sputum reflect asthma control status
by: Wenhui Chen, et al.
Published: (2025-01-01)